• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

20 年对大规模学校筛查中发现的乳糜泻患者的随访研究:对无麸质饮食和自身免疫的依从性。

20-Year Follow-up Study of Celiac Patients Identified in a Mass School Screening: Compliance to Gluten-Free Diet and Autoimmunity.

机构信息

Institute for Maternal and Child Health IRCCS Burlo Garofolo.

Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste.

出版信息

J Pediatr Gastroenterol Nutr. 2022 Jan 1;74(1):91-95. doi: 10.1097/MPG.0000000000003295.

DOI:10.1097/MPG.0000000000003295
PMID:34508048
Abstract

OBJECTIVES

To investigate the compliance to the gluten-free diet in a cohort of adult celiac patients 20 years after the diagnosis, received in childhood through a mass screening.

METHODS

This is an observational historic cohort follow-up study. It was carried out at the Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy. Two matched cohorts of adult celiac patients, diagnosed in childhood through a mass screening or for symptoms were enrolled. Adherence to the gluten free-diet and development of autoimmune diseases were investigated through a questionnaire administrated in the course of a phone interview.The primary study outcome was the adherence to the gluten-free diet, measured through the Biagi questionnaire, in the two cohorts of celiac patients.

RESULTS

We contacted 25 patients (mean age 28 years, 19 females) diagnosed with screening and 34 patients (mean age 25 years, 26 females) diagnosed in the same period for symptoms. After 20 years, in the cohort diagnosed with screening and in the cohort diagnosed for symptoms the adherence to the gluten-free diet was optimal in 14 (56%) and 26 (81%), improvable in 5 (20%) and 3 (9%), inadequate in 6 (24%) and 3 (9%), respectively. In the two cohorts, four patients (16%) and six patients (18%) developed other autoimmune diseases.

CONCLUSIONS

Twenty years after the diagnosis, near half of the patients diagnosed in a mass screening, does not have an optimal adherence to the gluten-free diet and a remarkable proportion of them have developed another autoimmune disease.

摘要

目的

调查通过大规模筛查在儿童时期确诊的成年乳糜泻患者在诊断后 20 年对无麸质饮食的依从性。

方法

这是一项观察性历史队列随访研究。它在意大利的里雅斯特母婴健康研究所(IRCCS Burlo Garofolo)进行。招募了两组通过大规模筛查或因症状而在儿童时期确诊的成年乳糜泻患者。通过电话访谈过程中的问卷调查来调查对无麸质饮食的依从性和自身免疫性疾病的发展情况。主要研究结果是通过比阿吉问卷测量两组乳糜泻患者对无麸质饮食的依从性。

结果

我们联系了 25 名(平均年龄 28 岁,19 名女性)通过筛查诊断的患者和 34 名(平均年龄 25 岁,26 名女性)同期因症状诊断的患者。20 年后,在筛查诊断组和症状诊断组中,无麸质饮食依从性最佳的分别有 14 名(56%)和 26 名(81%),可改善的分别有 5 名(20%)和 3 名(9%),不充分的分别有 6 名(24%)和 3 名(9%)。在这两个队列中,分别有 4 名(16%)和 6 名(18%)患者发生了其他自身免疫性疾病。

结论

在诊断后 20 年,近一半通过大规模筛查诊断的患者对无麸质饮食的依从性不理想,而且其中相当一部分患者已经发展出另一种自身免疫性疾病。

相似文献

1
20-Year Follow-up Study of Celiac Patients Identified in a Mass School Screening: Compliance to Gluten-Free Diet and Autoimmunity.20 年对大规模学校筛查中发现的乳糜泻患者的随访研究:对无麸质饮食和自身免疫的依从性。
J Pediatr Gastroenterol Nutr. 2022 Jan 1;74(1):91-95. doi: 10.1097/MPG.0000000000003295.
2
Letter to the Editor for the article "20-year follow-up study of celiac patients identified in a mass school screening: compliance to gluten-free diet and autoimmunity".致编辑的信:关于“大规模学校筛查中确诊的乳糜泻患者的20年随访研究:无麸质饮食依从性与自身免疫”一文
J Pediatr Gastroenterol Nutr. 2022 Apr 1;74(4):e101. doi: 10.1097/MPG.0000000000003351. Epub 2021 Nov 2.
3
Factors Associated With Adherence to a Gluten-Free Diet in Celiac Patients Diagnosed in Childhood as Compared to Adulthood.与成年期诊断的乳糜泻患者相比,儿童期诊断的乳糜泻患者坚持无麸质饮食的相关因素。
Gastroenterol Nurs. 2023;46(3):243-248. doi: 10.1097/SGA.0000000000000729. Epub 2023 Apr 11.
4
Long-term health and quality-of-life consequences of mass screening for childhood celiac disease: a 10-year follow-up study.儿童乳糜泻大规模筛查的长期健康及生活质量影响:一项10年随访研究
Pediatrics. 2009 Apr;123(4):e582-8. doi: 10.1542/peds.2008-2221.
5
Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet.乳糜泻患者自身免疫性疾病的发病率:无麸质饮食的保护作用。
Clin Gastroenterol Hepatol. 2008 Jul;6(7):753-8. doi: 10.1016/j.cgh.2007.12.022. Epub 2008 Feb 6.
6
Clinical benefit of gluten-free diet in screen-detected older celiac disease patients.筛查发现的老年乳糜泻患者无麸质饮食的临床获益。
BMC Gastroenterol. 2011 Dec 16;11:136. doi: 10.1186/1471-230X-11-136.
7
Coeliac disease in the ERA of the new ESPGHAN and BSPGHAN guidelines: a prospective cohort study.乳糜泻在新 ESPGHAN 和 BSPGHAN 指南时代:一项前瞻性队列研究。
Arch Dis Child. 2016 Feb;101(2):172-6. doi: 10.1136/archdischild-2015-309259. Epub 2015 Nov 17.
8
Adherence to gluten-free diet and follow-up of pediatric celiac disease patients, during childhood and after transition to adult care. gluten-free 饮食的依从性和儿童期乳糜泻患者的随访,在儿童期和过渡到成人期后。
Eur J Pediatr. 2021 Jun;180(6):1817-1823. doi: 10.1007/s00431-021-03939-x. Epub 2021 Jan 29.
9
At-Risk Screened Children with Celiac Disease are Comparable in Disease Severity and Dietary Adherence to Those Found because of Clinical Suspicion: A Large Cohort Study.患有乳糜泻的风险筛查儿童在疾病严重程度和饮食依从性方面与因临床怀疑而确诊的儿童相当:一项大型队列研究。
J Pediatr. 2017 Apr;183:115-121.e2. doi: 10.1016/j.jpeds.2016.12.077. Epub 2017 Jan 30.
10
Gluten-free diet adherence in children with screening-detected celiac disease using a prospective birth cohort study.前瞻性出生队列研究中通过筛查发现的乳糜泻患儿的无麸质饮食依从性。
PLoS One. 2023 Feb 2;18(2):e0275123. doi: 10.1371/journal.pone.0275123. eCollection 2023.

引用本文的文献

1
Celiac disease screening in children: evaluating the evidence, benefits, and challenges.儿童乳糜泻筛查:评估证据、益处及挑战
Front Pediatr. 2025 Apr 3;13:1562073. doi: 10.3389/fped.2025.1562073. eCollection 2025.
2
Coexisting Type 1 Diabetes, Persistent Symptoms, and Financial Issues Associate With Poorer Adherence to a Gluten-Free Diet in Celiac Disease After Transition From Pediatrics to Adult Care.从儿科过渡到成人护理后,1型糖尿病共存、持续症状和经济问题与乳糜泻患者对无麸质饮食的依从性较差有关。
Front Nutr. 2022 May 26;9:883220. doi: 10.3389/fnut.2022.883220. eCollection 2022.